Molecular and metabolic control of antitumor immunity by myeloid cells

Vincenzo Bronte - University of Verona

June, 03 2014
11:00 DKFZ Main Auditorium

Host: V. Umasky

Biosketch Vicenzo Bronte
Dr. Vincenzo Bronte is currently Head of the Immunology Section in the Department of Pathology and Diagnostics of Verona University and Head of the U.O.C of Immunology in the Policlinico G. B. Rossi Hospital. He is Full Professor of Immunology at the University of Verona.
His major achievements has been the definition and characterization of immunoregulatory cells, now called myeloid-derived suppressor cells (MDSCs), whose negative influence on antitumor immunity represents the major obstacle to a successful immunotherapy of cancer. Current projects in the laboratory are further exploring the cellular and molecular mechanisms underlying the biological properties of MDSCs, with particular attention to definition of novel drugs affecting their function to be used alone or in combination with active or passive immunotherapy approaches.
Dr. Bronte is section editor of Journal of Immunology, associate editor of Current Gene Therapy and Frontiers in Tumor Immunity, editorial board of Journal of Translational Medicine and Cancer Immunology Research, past consulting editor of Journal of Clinical Investigation. Dr. Bronte was awarded: in 2007 by the Accademia Nazionale dei Lincei (Rome, Italy) with the International Prize "Francesco De Luca" for scientific Oncology career; in 2008 by the Italian Foundation for Cancer Research (FIRC) with the Prize "Guido Venosta" for oncology researchers. He is member of the board of the Accademia Nazionale di Medicina and Italian Cancer Society (SIC), Italy.

to top
powered by webEdition CMS